D. Blair Macdonald

D. Blair Macdonald

Auto-generated profile, based on publicly available information

D. Blair Macdonald

Department of Radiology, University of Ottawa, ON, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in Canadian Association of Radiologists Journal
Verified
Journal Article
Open access
DMD. Blair Macdonald
D. Blair Macdonald
CHCasey Hurrell
Casey Hurrell
ACAndreu F. Costa
Andreu F. Costa
MMMatthew D.F. McInnes
Matthew D.F. McInnes
MOMartin E. O'MAlley
Martin E. O'MAlley
SHSwapnil Hiremath
Swapnil Hiremath
Iodinated contrast media (ICM) is one of the most frequently administered pharmaceuticals. In Canada, over 5.4 million computed tomography (CT) examinations were performed in 2019, of which 50% were contrast enhanced. Acute kidney injury (AKI) occurring after ICM administration was historically considered a common iatrogenic complication which was managed by screening patients, prophylactic strategies, and follow up evaluation of renal function. The Canadian Association of Radiologists (CAR) initially published guidelines on the prevention of contrast induced nephropathy in 2007, with an update in 2012. However, new developments in the field have led to the availability of safer contrast agents and changes in clinical practice, prompting a complete revision of the earlier recommendations. This revised guidance document was developed by a multidisciplinary CAR Working Group of radiologists and nephrologists, and summarizes changes in practice related to contrast administration, screening, and risk stratification since the last guideline. It reviews the scientific evidence for contrast associated AKI and provides consensus-based recommendations for its prevention and management in the Canadian healthcare context. This article is a joint publication in the Canadian Association of Radiologists Journal and Canadian Journal of Kidney Health and Disease, intended to inform both communities of practice.

11 January 2025 in Canadian Association of Radiologists Journal
Verified
Journal Article
Open access
ABAdam Byrne
Adam Byrne
DMD. Blair Macdonald
D. Blair Macdonald
IKIain D. C. Kirkpatrick
Iain D. C. Kirkpatrick
MPMagali Pham
Magali Pham
CGCourtney R. Green
Courtney R. Green
ACAndreu F. Costa
Andreu F. Costa
Contrast media, including iodinated contrast media and gadolinium-based contrast agents, are commonly administered pharmaceuticals with excellent safety profiles. However, a minority of the population may experience a hypersensitivity reaction following intravenous administration. Hypersensitivity reactions can be immediate or delayed, and range from mild, such as urticaria, to severe, including anaphylaxis. There is emerging evidence that longstanding pretreatment protocols, such as diphenhydramine and corticosteroids, are ineffective and have the potential for side effects and other harms. Moreover, the evidence for efficacy on which this practice is based is weak and outdated. A joint collaborative working group of representatives from the Canadian Association of Radiologists and the Canadian Society of Allergy and Clinical Immunology was assembled to inform medical professionals and hospital policies regarding hypersensitivity reactions to contrast media. The objectives of the working group were to provide an overview of the epidemiology, physiology, risk factors, and types of hypersensitivity reactions; to synthesize the evidence for pretreatment strategies that minimize the risk of a breakthrough reaction for both iodinated contrast media and gadolinium-based contrast agents; to review the allergy investigations used to evaluate patients with a history of severe hypersensitivity reaction; and to provide an overview of existing guidelines. Following appraisal of the evidence, the working group established recommendations based on consensus in this practice guidance.

1 April 2015 in Clinical Oncology
Verified
Journal Article
Closed access
EKErin Kennedy
Erin Kennedy
EVE.T. Vella
E.T. Vella
DMD. Blair Macdonald
D. Blair Macdonald
SWShun Wong
Shun Wong
RMR. McLeod
R. McLeod

1 January 2022 in Canadian Journal of Kidney Health and Disease
Verified
Journal Article
Open access
DMD. Blair Macdonald
D. Blair Macdonald
CHCasey Hurrell
Casey Hurrell
ACAndreu F. Costa
Andreu F. Costa
MMMatthew D. F. McInnes
Matthew D. F. McInnes
MOMartin O’malley
Martin O’malley
SHSwapnil Hiremath
Swapnil Hiremath
Purpose: Iodinated contrast media is one of the most frequently administered pharmaceuticals. In Canada, over 5.4 million computed tomography (CT) examinations were performed in 2019, of which 50% were contrast enhanced. Acute kidney injury (AKI) occurring after iodinated contrast administration was historically considered a common iatrogenic complication which was managed by screening patients, prophylactic strategies, and follow-up evaluation of renal function. The Canadian Association of Radiologists (CAR) initially published guidelines on the prevention of contrast induced nephropathy in 2007, with an update in 2012. However, new developments in the field have led to the availability of safer contrast agents and changes in clinical practice, prompting a complete revision of the earlier recommendations. Information sources: Published literature, including clinical trials, retrospective cohort series, review articles, and case reports, along with expert opinions from radiologists and nephrologists across Canada. Methods: The leadership of the CAR formed a working group of radiologists and nephrologists with expertise in contrast administration and patient management related to contrast-associated AKI. We conducted a comprehensive review of the published literature to evaluate the evidence about contrast as a cause of AKI, and to inform evidence-based recommendations. Based on the available literature, the working group developed consensus recommendations. Key Findings: The working group developed 21 recommendations, on screening, choice of iodinated contrast media, prophylaxis, medication considerations, and post contrast administration management. The key changes from the 2012 guidelines were (1) Simplification of screening to a simple questionnaire, and not delaying emergent examinations due to a need for creatinine measurements (2) Prophylaxis considerations only for patients with estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m2 (3) Not recommending the routine discontinuation of any drugs to decrease risk of AKI, except metformin when eGFR is less than 30 mL/min/1.73 m2 and (4) Not requiring routine follow up serum creatinine measurements post iodinated contrast administration. Limitations: We did not conduct a formal systematic review or meta-analysis. We did not evaluate our specific suggestions in the clinical environment. Implications: Given the importance of iodinated contrast media use in diagnosis and management, and the low risk of AKI after contrast use, these guidelines aim to streamline the processes around iodinated contrast use in most clinical settings. As newer evidence arises that may change or add to the recommendations provided, the working group will revise these guidelines.

24 September 2024 in Journal of the American College of Radiology
Verified
Journal Article
Open access
LCLucas Corallo
Lucas Corallo
DMD. Blair Macdonald
D. Blair Macdonald
FEFatma Eldehimi
Fatma Eldehimi
ANAnirudh Venugopalan Nair
Anirudh Venugopalan Nair
SMSimeon Mitchell
Simeon Mitchell
To identify the published standards for the classification and communication of critical actionable findings in emergency radiology, and the associated facilitators and barriers to communication and message management/dissemination of such findings. Search terms for resources pertaining to critical findings (CFs) in emergency radiology were applied to 2 databases (PubMed, Embase). Screening of hits using the following pre-established inclusion and exclusion criteria were performed by 3 analysts with subsequent consensus discussion for discrepancies: 1) The resources include any standards for the classification and/or communication of imaging findings as critical OR 2) The resource discusses any facilitators to the communication of CFs OR 3) The resource discusses any barriers to the communication of CFs. Resources with explicit focus on a pediatric population or predominant focus on artificial intelligence/natural language processing were omitted. Accompanying gray literature search was used to expand included resources. Data extraction included: year, country, resource type, scope/purpose, participants, context, standards to identifying/communicating CFs, facilitators/barriers, method type, recommendations, applicability, and disclosures. Seventy-six resources were included in the final analysis, including 16 societal/commission guidelines. Among the guidelines, no standardized list of CFs was identified, with typical recommendations suggesting application of a local policy. Communication standards included direct closed-loop communication for high acuity findings, with more flexible communication channels for less acute findings. Applied interventions for CFs management, most frequently fell into 4 categories: electronic (n=10), hybrid i.e., electronic/administrative (n = 3), feedback/education (n=5), and administrative (n=4). There are published standards, policies and interventions for the management of CFs in emergency radiology. 3-tier stratification (e.g. critical/urgent/incidental) based on time-sensitivity and severity is most common with most critical findings necessitating closed-loop communication. Awareness of systemic facilitators and barriers should inform local policy development. Electronic and administrative communication pathways are useful adjuncts. Further research should offer comparative analyses of different CF interventions with regards to cost-effectiveness, notification time, and user feedback.

26 December 2025 in Canadian Association of Radiologists Journal
Verified
Journal Article
Closed access
ABAdam Byrne
Adam Byrne
DMD. Blair Macdonald
D. Blair Macdonald
IKIain D. C. Kirkpatrick
Iain D. C. Kirkpatrick
MPMagali Pham
Magali Pham
ACAna Maria Copaescu
Ana Maria Copaescu
ACAndreu F. Costa
Andreu F. Costa